| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glutaminase activity | 6.48e-07 | 4 | 110 | 3 | GO:0004359 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 5.94e-05 | 185 | 111 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | spot adherens junction | 8.35e-05 | 3 | 111 | 2 | GO:0005914 | |
| GeneOntologyCellularComponent | integrator complex | 1.81e-04 | 21 | 111 | 3 | GO:0032039 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.29e-04 | 230 | 111 | 7 | GO:0098562 | |
| GeneOntologyCellularComponent | organelle outer membrane | 7.29e-04 | 279 | 111 | 7 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 7.61e-04 | 281 | 111 | 7 | GO:0019867 | |
| Domain | p53-like_TF_DNA-bd | 2.49e-04 | 53 | 108 | 4 | IPR008967 | |
| Domain | Glyco_hydro_38_C | 3.28e-04 | 5 | 108 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 3.28e-04 | 5 | 108 | 2 | PF09261 | |
| Domain | Glyco_hydro_57/38_cen | 3.28e-04 | 5 | 108 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38 | 3.28e-04 | 5 | 108 | 2 | PF01074 | |
| Domain | - | 3.28e-04 | 5 | 108 | 2 | 1.20.1270.50 | |
| Domain | - | 3.28e-04 | 5 | 108 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 3.28e-04 | 5 | 108 | 2 | SM00872 | |
| Domain | Glyco_hydro_38_N | 3.28e-04 | 5 | 108 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 3.28e-04 | 5 | 108 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 3.28e-04 | 5 | 108 | 2 | IPR015341 | |
| Domain | Glyco_hydro_38C | 3.28e-04 | 5 | 108 | 2 | PF07748 | |
| Domain | WD40_repeat_CS | 3.82e-04 | 164 | 108 | 6 | IPR019775 | |
| Domain | - | 4.89e-04 | 6 | 108 | 2 | 3.90.1290.10 | |
| Domain | STAT_TF_DNA-bd_sub | 6.83e-04 | 7 | 108 | 2 | IPR012345 | |
| Domain | STAT | 6.83e-04 | 7 | 108 | 2 | IPR001217 | |
| Domain | STAT_int | 6.83e-04 | 7 | 108 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 6.83e-04 | 7 | 108 | 2 | IPR013801 | |
| Domain | STAT_bind | 6.83e-04 | 7 | 108 | 2 | PF02864 | |
| Domain | STAT_int | 6.83e-04 | 7 | 108 | 2 | PF02865 | |
| Domain | Plectin | 6.83e-04 | 7 | 108 | 2 | PF00681 | |
| Domain | - | 6.83e-04 | 7 | 108 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 6.83e-04 | 7 | 108 | 2 | PF01017 | |
| Domain | - | 6.83e-04 | 7 | 108 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 6.83e-04 | 7 | 108 | 2 | IPR013799 | |
| Domain | Plectin_repeat | 6.83e-04 | 7 | 108 | 2 | IPR001101 | |
| Domain | STAT_TF_coiled-coil | 6.83e-04 | 7 | 108 | 2 | IPR015988 | |
| Domain | - | 6.83e-04 | 7 | 108 | 2 | 2.60.40.630 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 6.83e-04 | 7 | 108 | 2 | IPR011330 | |
| Domain | PLEC | 6.83e-04 | 7 | 108 | 2 | SM00250 | |
| Domain | STAT_TF_alpha | 9.07e-04 | 8 | 108 | 2 | IPR013800 | |
| Domain | PDZ | 1.37e-03 | 141 | 108 | 5 | PF00595 | |
| Domain | PDZ | 1.69e-03 | 148 | 108 | 5 | SM00228 | |
| Domain | PTBI | 1.76e-03 | 11 | 108 | 2 | SM00310 | |
| Domain | - | 1.79e-03 | 150 | 108 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.85e-03 | 151 | 108 | 5 | PS50106 | |
| Domain | PDZ | 1.90e-03 | 152 | 108 | 5 | IPR001478 | |
| Domain | IRS_PTB | 2.11e-03 | 12 | 108 | 2 | PS51064 | |
| Domain | IRS | 2.88e-03 | 14 | 108 | 2 | PF02174 | |
| Domain | - | 2.88e-03 | 14 | 108 | 2 | 2.60.40.1180 | |
| Domain | IRS_PTB | 2.88e-03 | 14 | 108 | 2 | IPR002404 | |
| Domain | - | 3.22e-03 | 333 | 108 | 7 | 2.130.10.10 | |
| Domain | Glyco_hydro_b | 3.31e-03 | 15 | 108 | 2 | IPR013780 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.33e-03 | 335 | 108 | 7 | IPR015943 | |
| Domain | Gal_mutarotase_SF_dom | 4.26e-03 | 17 | 108 | 2 | IPR011013 | |
| Domain | - | 4.26e-03 | 17 | 108 | 2 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 4.26e-03 | 17 | 108 | 2 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 4.26e-03 | 17 | 108 | 2 | PS00484 | |
| Domain | TY | 4.26e-03 | 17 | 108 | 2 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 4.26e-03 | 17 | 108 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 4.26e-03 | 17 | 108 | 2 | PF00086 | |
| Domain | WD40 | 4.67e-03 | 268 | 108 | 6 | SM00320 | |
| Domain | WD40_repeat | 5.01e-03 | 272 | 108 | 6 | IPR001680 | |
| Domain | WD_REPEATS_1 | 5.56e-03 | 278 | 108 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 5.66e-03 | 279 | 108 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 5.66e-03 | 279 | 108 | 6 | PS50294 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 2.93e-07 | 11 | 79 | 4 | M27195 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 5.83e-06 | 7 | 79 | 3 | M27907 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 8.91e-06 | 24 | 79 | 4 | M519 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.24e-05 | 26 | 79 | 4 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 1.24e-05 | 26 | 79 | 4 | MM15896 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 4.70e-05 | 36 | 79 | 4 | M542 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 7.34e-05 | 15 | 79 | 3 | MM14536 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 9.55e-05 | 43 | 79 | 4 | MM15864 | |
| Pathway | WP_IL4_SIGNALING | 2.34e-04 | 54 | 79 | 4 | M39720 | |
| Pathway | PID_IL2_1PATHWAY | 2.51e-04 | 55 | 79 | 4 | M122 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.07e-04 | 5 | 79 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 3.07e-04 | 5 | 79 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 3.07e-04 | 5 | 79 | 2 | M49006 | |
| Pathway | REACTOME_IRS_ACTIVATION | 3.07e-04 | 5 | 79 | 2 | M27707 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 3.56e-04 | 25 | 79 | 3 | M27865 | |
| Pathway | BIOCARTA_GH_PATHWAY | 4.50e-04 | 27 | 79 | 3 | M9043 | |
| Pathway | PID_IL4_2PATHWAY | 4.50e-04 | 64 | 79 | 4 | M28 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 4.58e-04 | 6 | 79 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 4.58e-04 | 6 | 79 | 2 | MM15621 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 5.06e-04 | 66 | 79 | 4 | MM15925 | |
| Pathway | WP_AGERAGE_PATHWAY | 5.06e-04 | 66 | 79 | 4 | M39420 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 5.63e-04 | 335 | 79 | 8 | MM14503 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 6.39e-04 | 7 | 79 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 6.39e-04 | 7 | 79 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 6.39e-04 | 7 | 79 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 6.39e-04 | 7 | 79 | 2 | M47430 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 6.39e-04 | 7 | 79 | 2 | M19489 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 7.42e-04 | 73 | 79 | 4 | MM16641 | |
| Pathway | PID_EPO_PATHWAY | 8.19e-04 | 33 | 79 | 3 | M233 | |
| Pathway | BIOCARTA_GH_PATHWAY | 8.19e-04 | 33 | 79 | 3 | MM1404 | |
| Pathway | WP_PROLACTIN_SIGNALING | 8.63e-04 | 76 | 79 | 4 | M39601 | |
| Pathway | WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING | 1.06e-03 | 36 | 79 | 3 | M39569 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 1.06e-03 | 36 | 79 | 3 | MM1418 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.09e-03 | 9 | 79 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.09e-03 | 9 | 79 | 2 | MM1419 | |
| Pathway | REACTOME_PI3K_AKT_ACTIVATION | 1.09e-03 | 9 | 79 | 2 | M714 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.09e-03 | 9 | 79 | 2 | M8066 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 1.15e-03 | 37 | 79 | 3 | M8615 | |
| Pathway | REACTOME_SIGNAL_ATTENUATION | 1.36e-03 | 10 | 79 | 2 | M14236 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.36e-03 | 10 | 79 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.36e-03 | 10 | 79 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.36e-03 | 10 | 79 | 2 | MM15618 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.43e-03 | 87 | 79 | 4 | MM15915 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.65e-03 | 11 | 79 | 2 | MM15578 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.97e-03 | 12 | 79 | 2 | M27893 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.09e-03 | 411 | 79 | 8 | M735 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 MAN2A2 INPP5E GEMIN5 AMBRA1 IRS1 RHOT2 TPCN1 CCDC88C C2CD3 NADSYN1 MDN1 NFKB2 KBTBD11 IRS2 LRRC14 PLEC HERC1 SPEN MED12 | 3.80e-10 | 1105 | 112 | 20 | 35748872 |
| Pubmed | MAN2B2 ARHGAP23 RTEL1 RICTOR TRIM14 PTGFRN ELFN2 SHROOM4 CCDC88C GLS LRRC14 MED12 UNC80 | 7.57e-09 | 493 | 112 | 13 | 15368895 | |
| Pubmed | 1.07e-06 | 418 | 112 | 10 | 34709266 | ||
| Pubmed | 1.80e-06 | 8 | 112 | 3 | 27879203 | ||
| Pubmed | KCTD9 CAD OGT CENPF SYNE1 HCN3 PPFIA3 SLC12A5 CCDC88C MDN1 FRMPD3 GNB2 CNOT1 NIPBL | 2.75e-06 | 963 | 112 | 14 | 28671696 | |
| Pubmed | CAD OGT CARMIL2 ARHGAP23 SYNE1 GEMIN5 PPFIA3 ELFN2 SLC12A5 NWD2 CRACDL KBTBD11 PLEC ALDH1B1 GNB2 CNOT1 CACNA2D3 | 3.36e-06 | 1431 | 112 | 17 | 37142655 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CENPF STAT5A CRNKL1 MDN1 NID1 IRS2 HERC1 TMEM109 CNOT1 MED12 | 5.00e-06 | 497 | 112 | 10 | 36774506 |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 7.98e-06 | 84 | 112 | 5 | 25670202 | |
| Pubmed | CAD EPPK1 CENPF GEMIN5 CRNKL1 MDN1 PLEC SPEN CNOT1 NIPBL MED12 | 8.88e-06 | 653 | 112 | 11 | 22586326 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23151802 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26999798 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17222321 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 1.03e-05 | 2 | 112 | 2 | 20233708 | |
| Pubmed | Insulin receptor substrate-1/2 mediates IL-4-induced migration of human airway epithelial cells. | 1.03e-05 | 2 | 112 | 2 | 19447894 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 1.03e-05 | 2 | 112 | 2 | 16775227 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 1.03e-05 | 2 | 112 | 2 | 31443474 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17447893 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12377952 | ||
| Pubmed | Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. | 1.03e-05 | 2 | 112 | 2 | 17361103 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 9495343 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 37550630 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 33839150 | ||
| Pubmed | Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics. | 1.03e-05 | 2 | 112 | 2 | 33270683 | |
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 1.03e-05 | 2 | 112 | 2 | 21127177 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16289657 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25552366 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25470773 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17499243 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15975995 | ||
| Pubmed | Systematic modeling for the insulin signaling network mediated by IRS(1) and IRS(2). | 1.03e-05 | 2 | 112 | 2 | 24703981 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 27708333 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 1.03e-05 | 2 | 112 | 2 | 21431790 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16115927 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23275557 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 28500076 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21826656 | ||
| Pubmed | Impairment of bone healing by insulin receptor substrate-1 deficiency. | 1.03e-05 | 2 | 112 | 2 | 14736890 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11867689 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7720707 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17928362 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 1.03e-05 | 2 | 112 | 2 | 15980098 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21356519 | ||
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 1.03e-05 | 2 | 112 | 2 | 27264955 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22994406 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15340066 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 22159083 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15069074 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 20008792 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19596788 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 33199496 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 20545557 | ||
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 1.03e-05 | 2 | 112 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 1.03e-05 | 2 | 112 | 2 | 12901872 | |
| Pubmed | Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis. | 1.03e-05 | 2 | 112 | 2 | 19259821 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12810606 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12055235 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11522686 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 34449768 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 28074064 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 36755813 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 20074531 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 7675087 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 16502315 | ||
| Pubmed | Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. | 1.03e-05 | 2 | 112 | 2 | 29717275 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 11546755 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12217382 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25333863 | ||
| Pubmed | Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphisms. | 1.03e-05 | 2 | 112 | 2 | 12475767 | |
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 1.03e-05 | 2 | 112 | 2 | 12421978 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 9852045 | ||
| Pubmed | Variations in insulin secretion in carriers of gene variants in IRS-1 and -2. | 1.03e-05 | 2 | 112 | 2 | 11872698 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 31599926 | ||
| Pubmed | Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. | 1.03e-05 | 2 | 112 | 2 | 11259600 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 19966185 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21704724 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 10594041 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 12213887 | ||
| Pubmed | Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis. | 1.03e-05 | 2 | 112 | 2 | 22523112 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 21036145 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 27247938 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 10486277 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 17641282 | ||
| Pubmed | Night-Shift Work Duration and Risk of Colorectal Cancer According to IRS1 and IRS2 Expression. | 1.03e-05 | 2 | 112 | 2 | 31666286 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 34537327 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 25310961 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 38618957 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 1.03e-05 | 2 | 112 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 1.03e-05 | 2 | 112 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 1.03e-05 | 2 | 112 | 2 | 30377054 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 1.03e-05 | 2 | 112 | 2 | 32790723 | |
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 1.03e-05 | 2 | 112 | 2 | 8732682 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 18492722 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26717567 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 10066807 | ||
| Pubmed | sh- Ambra1 inhibits IRS-1/PI3K/Akt signalling pathway to reduce autophagy in gestational diabetes. | 1.03e-05 | 2 | 112 | 2 | 38497391 | |
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 10835485 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 35464049 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 26991655 | ||
| Pubmed | 1.03e-05 | 2 | 112 | 2 | 15572028 | ||
| Interaction | TOP3B interactions | CAD EPPK1 MAN2A2 RTEL1 CENPF INPP5E GEMIN5 AMBRA1 IRS1 RHOT2 TPCN1 CCDC88C C2CD3 NADSYN1 MDN1 NFKB2 KBTBD11 IRS2 LRRC14 PLEC HERC1 SPEN CNOT1 MED12 | 1.00e-06 | 1470 | 110 | 24 | int:TOP3B |
| Cytoband | 2p22-p21 | 1.64e-04 | 8 | 112 | 2 | 2p22-p21 | |
| Cytoband | 20p11.2 | 3.20e-04 | 11 | 112 | 2 | 20p11.2 | |
| Cytoband | 18q12 | 4.52e-04 | 13 | 112 | 2 | 18q12 | |
| Cytoband | Xq13 | 4.52e-04 | 13 | 112 | 2 | Xq13 | |
| Cytoband | Xq26.3 | 6.04e-04 | 67 | 112 | 3 | Xq26.3 | |
| Cytoband | 4p16.1 | 9.77e-04 | 79 | 112 | 3 | 4p16.1 | |
| Cytoband | 5q35 | 1.44e-03 | 23 | 112 | 2 | 5q35 | |
| Cytoband | 8q24 | 2.14e-03 | 28 | 112 | 2 | 8q24 | |
| Cytoband | 7q22 | 3.92e-03 | 38 | 112 | 2 | 7q22 | |
| Cytoband | 4p14 | 4.77e-03 | 42 | 112 | 2 | 4p14 | |
| GeneFamily | Mannosidases alpha class 2 | 1.73e-04 | 5 | 76 | 2 | 1194 | |
| GeneFamily | PDZ domain containing | 4.49e-04 | 152 | 76 | 5 | 1220 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.80e-04 | 8 | 76 | 2 | 939 | |
| GeneFamily | Fucosyltransferases|Blood group antigens | 1.32e-03 | 13 | 76 | 2 | 434 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.24e-07 | 178 | 111 | 7 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.63e-07 | 198 | 111 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-06 | 171 | 111 | 6 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.48e-06 | 177 | 111 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-06 | 179 | 111 | 6 | dabecd283c1f0f71a66b804c99be8bd48ea36e35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.84e-06 | 184 | 111 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.50e-06 | 187 | 111 | 6 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.73e-06 | 188 | 111 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.21e-06 | 190 | 111 | 6 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-06 | 191 | 111 | 6 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.46e-06 | 191 | 111 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 192 | 111 | 6 | a42aed9e563f5f4af029b8804c104f11ad227a8f | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.98e-06 | 193 | 111 | 6 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 197 | 111 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 198 | 111 | 6 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 198 | 111 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 198 | 111 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 198 | 111 | 6 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 111 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 111 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.62e-05 | 157 | 111 | 5 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.76e-05 | 158 | 111 | 5 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 163 | 111 | 5 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-05 | 168 | 111 | 5 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.37e-05 | 168 | 111 | 5 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | severe_influenza-gd_T|World / disease group, cell group and cell class (v2) | 6.55e-05 | 169 | 111 | 5 | 6d514dd2d1e5253bce49279f43aa2fa2b7c2653e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.92e-05 | 171 | 111 | 5 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.31e-05 | 173 | 111 | 5 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 174 | 111 | 5 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-05 | 176 | 111 | 5 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 177 | 111 | 5 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 177 | 111 | 5 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 177 | 111 | 5 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 177 | 111 | 5 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.37e-05 | 178 | 111 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.82e-05 | 180 | 111 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.82e-05 | 180 | 111 | 5 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 8.82e-05 | 180 | 111 | 5 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.29e-05 | 182 | 111 | 5 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 185 | 111 | 5 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.05e-04 | 187 | 111 | 5 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.08e-04 | 188 | 111 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 189 | 111 | 5 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 189 | 111 | 5 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 189 | 111 | 5 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 190 | 111 | 5 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 192 | 111 | 5 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 192 | 111 | 5 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 192 | 111 | 5 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 192 | 111 | 5 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 193 | 111 | 5 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 193 | 111 | 5 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.25e-04 | 194 | 111 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 194 | 111 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 195 | 111 | 5 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 195 | 111 | 5 | eb2003d4f15cad213d17eda8ab7479f5a0c62164 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 195 | 111 | 5 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-04 | 196 | 111 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 196 | 111 | 5 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 196 | 111 | 5 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 198 | 111 | 5 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 198 | 111 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 198 | 111 | 5 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 198 | 111 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 198 | 111 | 5 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 198 | 111 | 5 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 198 | 111 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-04 | 199 | 111 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-04 | 199 | 111 | 5 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-04 | 199 | 111 | 5 | 9c2db0bb94cba71a3cc1827844da090e213e0258 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 200 | 111 | 5 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.44e-04 | 200 | 111 | 5 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 5.41e-06 | 196 | 111 | 8 | 4779_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.62e-06 | 197 | 111 | 8 | 5343_DN | |
| Drug | Quinacrine dihydrochloride dihydrate [6151-30-0]; Down 200; 7.8uM; HL60; HG-U133A | 3.60e-05 | 186 | 111 | 7 | 1563_DN | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; HL60; HG-U133A | 4.55e-05 | 193 | 111 | 7 | 1546_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; HL60; HT_HG-U133A | 4.55e-05 | 193 | 111 | 7 | 2202_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 4.86e-05 | 195 | 111 | 7 | 5228_DN | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.02e-05 | 196 | 111 | 7 | 2627_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 1634_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 4829_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 5.19e-05 | 197 | 111 | 7 | 1507_DN | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 3219_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 6502_DN | |
| Drug | minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA | 5.36e-05 | 198 | 111 | 7 | 1135_DN | |
| Drug | DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A | 5.36e-05 | 198 | 111 | 7 | 2877_DN | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; HL60; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 1305_DN | |
| Drug | SC 19220; Down 200; 10uM; MCF7; HT_HG-U133A | 5.53e-05 | 199 | 111 | 7 | 7090_DN | |
| Disease | blood vanadium measurement | 1.85e-04 | 30 | 109 | 3 | EFO_0021533 | |
| Disease | Combined immunodeficiency | 4.72e-04 | 41 | 109 | 3 | C0494261 | |
| Disease | Prostatic Neoplasms | 4.75e-04 | 616 | 109 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.75e-04 | 616 | 109 | 9 | C0376358 | |
| Disease | amnestic disorder (implicated_via_orthology) | 4.79e-04 | 9 | 109 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 6.32e-04 | 105 | 109 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Basal cell carcinoma | 7.28e-04 | 11 | 109 | 2 | C0007117 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 7.98e-04 | 49 | 109 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | basal cell carcinoma (is_implicated_in) | 8.71e-04 | 12 | 109 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 8.71e-04 | 12 | 109 | 2 | DOID:3319 (is_marker_for) | |
| Disease | uterine fibroid | 8.79e-04 | 199 | 109 | 5 | EFO_0000731 | |
| Disease | Polydactyly | 9.48e-04 | 117 | 109 | 4 | C0152427 | |
| Disease | central nervous system cancer, glioblastoma multiforme | 1.20e-03 | 14 | 109 | 2 | EFO_0000326, EFO_0000519 | |
| Disease | obesity (implicated_via_orthology) | 1.24e-03 | 215 | 109 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | CCL2 measurement | 1.25e-03 | 126 | 109 | 4 | EFO_0004749 | |
| Disease | platelet component distribution width | 1.97e-03 | 755 | 109 | 9 | EFO_0007984 | |
| Disease | Malignant neoplasm of breast | NPBWR1 CENPF SYNE1 SPATA18 OCA2 GRM6 STAT5A SPEN NIPBL MED12 MACIR | 2.10e-03 | 1074 | 109 | 11 | C0006142 |
| Disease | anorectal malformation | 2.22e-03 | 19 | 109 | 2 | MONDO_0019938 | |
| Disease | triacylglycerol 58:9 measurement | 2.98e-03 | 22 | 109 | 2 | EFO_0010443 | |
| Disease | osteoporosis (biomarker_via_orthology) | 2.98e-03 | 22 | 109 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | Granulomatous Slack Skin | 2.98e-03 | 22 | 109 | 2 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 3.25e-03 | 23 | 109 | 2 | C0079773 | |
| Disease | electrocardiography | 3.58e-03 | 530 | 109 | 7 | EFO_0004327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAARFSSYLLSRARK | 86 | O43414 | |
| LGSRDLALSVAALSY | 201 | Q6F5E8 | |
| SLQGRTARYSSAAAL | 11 | P30837 | |
| SSRGLCEYRASLLAG | 166 | Q3I5F7 | |
| ARLLTYNAARLLEAG | 346 | P45954 | |
| AASRLRAAETADGKY | 16 | Q9UGM1 | |
| YSLVLELSDSGAFRR | 361 | Q9HDC9 | |
| RAYDTASAERRLSGT | 336 | P32238 | |
| SSLISLSRYDGAGSR | 696 | Q9C0C7 | |
| LRLAYSAAAAHSRGL | 466 | Q96SC8 | |
| SALRRAAFSGNLTAL | 16 | Q9ULI1 | |
| RRYLLSREVSGLSAS | 136 | Q04671 | |
| AYTGDVSALRRFALS | 561 | O94925 | |
| RNAERTATAGRLLYD | 51 | Q9NVR2 | |
| GLTDLSSARARSYGA | 331 | O95907 | |
| SSSGVRATLRLYAES | 511 | Q15124 | |
| YSLVERRLGDRALSS | 491 | Q9Y5I1 | |
| SGADLSRLDLRYINF | 226 | Q7L273 | |
| YLQRGLSLDRAFSEA | 2376 | Q9NU22 | |
| LFLSGSKRYLSDLAR | 376 | Q3ZCV2 | |
| ALAYRLTDLGSRLLS | 176 | Q9P2G4 | |
| LGADCARYTTLSLLR | 86 | Q9BW11 | |
| RSYLEGSLLASGALL | 271 | Q9NRR6 | |
| SGLDSLGRYRSSCSL | 641 | O75145 | |
| ALLSRFSDSYSQARL | 301 | Q8TC71 | |
| YALSGRRNVDLDLAA | 1526 | Q15751 | |
| ARTLLARAAGLYRSV | 2886 | Q15751 | |
| LLGFYSRCLRSGTSA | 636 | P56696 | |
| EYLLASGSSDRTIRF | 201 | Q9BVA0 | |
| LSRAFSLASADLLRA | 1801 | Q9P219 | |
| YRLSEQDGSFSLARI | 551 | P38570 | |
| LDAGLARSSRLYKTR | 96 | Q96GV9 | |
| LGSDSGSTATRYLLR | 31 | Q9H5P4 | |
| ALELSGALRFYDRSD | 56 | P14543 | |
| RYLSSAERAGLAASL | 226 | Q9NP08 | |
| FSREELTGYLLRASA | 516 | Q8TDF6 | |
| RVASLDYLGTVAARL | 1606 | Q6KC79 | |
| RSDGSSAERCILAYL | 961 | Q93074 | |
| VAFSRSGRLLLAGYD | 276 | P62879 | |
| LARGARDTRLTDGSY | 476 | Q9P1Z3 | |
| LSTSSGRLLYAATAD | 791 | P35568 | |
| IAGYRESAAFLLRSA | 411 | Q96MY1 | |
| AYSAELRTRASGVLL | 31 | Q96P69 | |
| AAGLRALRYLIQDSS | 101 | Q6R327 | |
| TVSSLDYSRDGLARV | 701 | Q6R327 | |
| LRSTSLSLKYRDGAS | 686 | Q6NV74 | |
| GSRASTLRRNDSIYE | 191 | Q96EY5 | |
| GRAADALIAISNYRL | 46 | Q9NYA4 | |
| YRALTDLVSEGRAAA | 136 | Q9Y4H2 | |
| AYERGLSLDSFLRAS | 256 | Q8NC74 | |
| LELRSYSLAGRHGST | 26 | Q9BZJ0 | |
| LGARLLDTCSRDTYA | 91 | O15303 | |
| AYVDLARLGERSART | 1516 | Q4AC94 | |
| SLSSLGDSSFYRALL | 1486 | P49454 | |
| SRGASALLAAALLYA | 11 | Q8IZS8 | |
| GDYASVRTALLAARA | 546 | Q8WW52 | |
| RARSYTLDNSLGAEA | 626 | Q5JV73 | |
| DYRSLAQRSLLTLSG | 621 | Q14CM0 | |
| ALRDSRTRALLFYGT | 111 | Q495W5 | |
| YNSSGRDLRRALFSL | 116 | Q2V2M9 | |
| LYSLAAAHARRSGLA | 531 | P49641 | |
| SSLKGLARRASALLY | 366 | Q9Y2E5 | |
| LIARYAARLAAESSS | 436 | Q9Y4J8 | |
| LRAARAYLQALESSL | 461 | Q8NFJ9 | |
| ARAAGLLSTYRAFLS | 1241 | P39059 | |
| RSGAAARGRAALLLY | 576 | Q8NAC3 | |
| ARGRAALLLYSADDS | 581 | Q8NAC3 | |
| RVAGRTYSAARAVSL | 146 | P48145 | |
| FDRAVAAYLRALSLS | 241 | O15294 | |
| DGIRGLSLSAARYAL | 666 | Q9H2X9 | |
| RLDTVGSDAYRLSVS | 221 | Q9P2B2 | |
| GSDAYRLSVSRALSA | 226 | Q9P2B2 | |
| RLSVSRALSADQGSY | 231 | Q9P2B2 | |
| SAYLADARRALGSAG | 1061 | Q9NZ71 | |
| SRLSLSASFEALAIY | 6 | Q9H426 | |
| YSLSRFRLLTGSLEA | 7151 | Q8NF91 | |
| LRRFGYSDALELTAD | 271 | Q8IXI1 | |
| SAADILSGAASRRRY | 31 | Q9Y2G5 | |
| TDAFAGTSLARLNLR | 521 | O94933 | |
| ASGYVSRAAREELLA | 2541 | P58107 | |
| LASGYVSRAAREELL | 3076 | P58107 | |
| LASGYVSRAAREELL | 4141 | P58107 | |
| VRLSRSAAARGSYGA | 21 | P0DMW4 | |
| VRLSRSAAARGSYGA | 21 | P0DMW5 | |
| DLSSYRAISSLDLLG | 1011 | Q9ULL8 | |
| FSIRSLADRLGDLNY | 651 | P51692 | |
| LTALRLLLADAYSGR | 181 | O94819 | |
| FSIRSLADRLGDLSY | 651 | P42229 | |
| DATSGADADLLLRYR | 1671 | A5YKK6 | |
| GSRADYDTLSLRSLR | 171 | Q9Y446 | |
| AGLSSVRLLSLYDNR | 626 | O75094 | |
| NRLSAPSYLARSLAD | 91 | Q9H4B6 | |
| GYDSLSNRLSILDRL | 76 | Q8WYP3 | |
| LRREGLAESTSQAAY | 2781 | Q8N2C7 | |
| SVDSARRYSLCGASL | 301 | Q8N8G2 | |
| SALYESSRLSFLLRD | 1396 | Q96T58 | |
| LAEAGILATSTRDLY | 371 | A6NJ88 | |
| ARSGLTLNRYSTSLA | 421 | O95935 | |
| LYSFSEQTRSLDGRL | 101 | Q15796 | |
| CSSIKAGRRSSYLLA | 601 | Q9P227 | |
| GRYRLSTRSDLSLGS | 191 | Q96RF0 | |
| HSAVLRDLRSGTLYS | 3716 | P22105 | |
| ALLRAVVRSYDSGSF | 1226 | Q8TEQ6 | |
| LASRAYIKTAGLRST | 271 | Q9BTF0 | |
| IDRSALDQYRAGTLS | 4351 | Q15149 | |
| RLSRSSALASKATGY | 686 | P27708 | |
| YALLSRLTGSRASGA | 196 | Q9BVC6 | |
| YASLRRRGASAAARL | 341 | Q14142 | |
| LYREARGASSDVTRL | 726 | Q9ULQ1 | |
| AADGIRLYNSLKSRS | 411 | Q9NZI7 | |
| ARLAARPYSATAAAA | 41 | P23025 | |
| LDRRTASLSAAYACG | 231 | Q53S58 | |
| FLRGSDYAIRLAAQS | 986 | P01266 | |
| ASRLLAADALYRLGR | 51 | A8MYJ7 | |
| AAALVTLAAYLASRD | 156 | Q6ZNR0 | |
| TRGSTAYLDIALDAL | 181 | Q9Y493 | |
| NRLSRLDGATFASLA | 161 | Q5R3F8 | |
| ASYAFLREALRSSVG | 176 | Q15048 | |
| YRAEISSRNLAASRA | 281 | Q6IA69 | |
| RSARALLDYGVTADA | 456 | Q00653 |